Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share - Forecast 2032
Digital PCR (dPCR) and Real-time PCR (qPCR) Market By Product & Services (Instruments, Reagents & Consumables, and Software & Services), By Application (Clinical, Research, and Forensics), By End-User (Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories), and By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 7.98 Billion | USD 12.28 Billion | 4.9% | 2023 |
What is the market size of the digital PCR (dPCR) and real-time PCR (qPCR) industry?
The global Digital PCR (dPCR) and Real-time PCR (qPCR) market size accrued earnings worth approximately USD 7.98 billion in 2023 and is predicted to gain revenue of about USD 12.28 billion by 2032, is set to record a CAGR of nearly 4.9% over the period from 2024 to 2032.
-and-real-time-pcr-(qpcr)-market-size.png)
The report covers in-depth analysis of the strategies adopted by major competitors in the global Digital PCR (dPCR) and Real-time PCR (qPCR) market. To understand the competitive landscape in the global Digital PCR (dPCR) and Real-time PCR (qPCR) market, an analysis of Porter’s Five Forces model is also included. The research study comprises of market attractiveness analysis, wherein all the segments are benchmarked on the basis of their market size and growth rate.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | Digital PCR (dPCR) and Real-time PCR (qPCR) Market |
| Market Size in 2023 | USD 7.98 Billion |
| Market Forecast in 2032 | USD 12.28 Billion |
| Growth Rate | CAGR of 4.90% |
| Number of Pages | 206 |
| Key Companies Covered | Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Qiagen, Takara, Agilent, Danaher, Abbott, Merck, Becton Dickinsonand QIAGEN N.V. |
| Segments Covered | By Application, By Type, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 - 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation Analysis
The research study provides a decisive view on the global Digital PCR (dPCR) and Real-time PCR (qPCR) market based on Source, Packaging Process, Raw Material, End-Use, and Region. All the segments of the market have been analyzed based on the past, present, and future trends. The market is estimated from 2023 to 2032.
The nonstop technological innovations in PCR tools and increasing prevalence of target genetic disorders & infectious diseases are the primary factors anticipated to bolster the global Digital PCR (dPCR) and Real-time PCR (qPCR) market during the forecast period. Additionally, the increasing grants, investments, and funds will further help the market propel in the coming years. The mounting application of biomarker profiling for ailment diagnostics and efficacious accomplishment of the Human Genome Project is expected to fuel the growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) market. The growing advancements in the R&D activities are projected to surge the demand for innovative Digital PCR (dPCR) and Real-time PCR (qPCR) techniques.
The proven effectiveness of dPCR and qPCR analysis in the estimation and diagnosis of disease-causing microbes will escalate the application of clinical diagnostic tests such as qPCR and dPCR analysis, thereby augmenting the market growth. The high costs of the instruments, especially dPCR, and the technical limitations of PCR are likely to restrain the market growth. Furthermore, the large capital investments and intricate scientific validation on a nanoscale level during the development of qPCR and dPCR instruments coupled with the demand for specific reagents depending on the end-use will hamper the Digital PCR (dPCR) and Real-time PCR (qPCR) market growth.
On the basis of product & services, the global Digital PCR (dPCR) and Real-time PCR (qPCR) market is divided into Instruments, Reagents & Consumables, and Software & Services. Based on application, the market for Digital PCR (dPCR) and Real-time PCR (qPCR) is segregated into Clinical, Research, and Forensics. In terms of end-user, the market is categorized into Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories.
The regional segmentation comprises the past, present, and estimated demand for the Middle East & Africa, North America, Asia Pacific, Latin America, and Europe. The regional segment is further split into the U.S., Canada, Mexico, UK, France, Germany, China, Japan, India, South Korea, Brazil, and Argentina among others.
Some of the key players,
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Qiagen
- Takara
- Agilent
- Danaher
- Abbott
- Merck
- Becton Dickinsonand QIAGEN N.V.
The report categorizes the global Digital PCR (dPCR) and Real-time PCR (qPCR) market into:
By Products & Services
- Instruments
- Reagents & Consumables
- Software & Services
By Application
-
Clinical
- Infectious Diseases Testing
- Oncology Testing
- Blood Screening
- Transplant Diagnostics
- Others
- Research
- Forensic
By End-User
- Hospitals and Diagnostic Centers
- Research Laboratories and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Research Organizations
- Forensic Laboratories
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table Of Content
Methodology
FrequentlyAsked Questions
dPCR and qPCR are molecular techniques used to amplify and quantify DNA or RNA. They are widely used in diagnostics, research, and disease detection.
The global digital PCR (dPCR) and real-time PCR (qPCR) market is expected to be driven by the molecular diagnostics demand, infectious disease testing, and precision medicine applications.
According to study, the global digital PCR (dPCR) and real-time PCR (qPCR) market size was worth around USD 7.98 Billion in 2023 and is predicted to grow to around USD 12.28 Billion By 2032.
The global digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 4.9% during the forecast period from 2024-2032.
The global digital PCR (dPCR) and real-time PCR (qPCR) industry is projected to be challenged by Challenges involve high instrument and reagent costs, technical complexity, and need for skilled operators. Standardization and reimbursement issues affect clinical adoption.
The Opportunities include precision diagnostics, oncology and infectious disease testing, and expanding clinical research use. Automation, multiplexing, and decentralized labs drive adoption will offer significant growth opportunities in the digital PCR (dPCR) and real-time PCR (qPCR) market.
Ultra-sensitive nucleic acid quantification; multiplex and rapid testing advancements; growing use in oncology and infectious disease diagnostics are the emerging trends and innovations impacting the digital PCR (dPCR) and real-time PCR (qPCR) market.
The global digital PCR (dPCR) and real-time PCR (qPCR) market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global digital PCR (dPCR) and real-time PCR (qPCR) market are; Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Qiagen, Takara, Agilent, Danaher, Abbott, Merck, Becton Dickinsonand QIAGEN N.V. and others.
The report explores crucial aspects of the digital PCR (dPCR) and real-time PCR (qPCR) market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
